Efficiency of interferon therapy in patients with essential thrombocythemia or polycythemia vera

Autor: M A Sokolova, A G Turkina, A L Melikian, A B Sudarikov, S A Treglazova, O A Shukhov, E G Gemdzhian, A О Abdullaev, A M Kovrigina, A V Misyurin, Yu V Pliskunova, V L Ivanova, T N Moiseeva

Publikováno v: Терапевтический архив, Vol 88, Iss 12, Pp 69-77 (2016)

Aim. To evaluate the efficiency of interferon (IFN) therapy in patients with essential thrombocythemia (ET) and polycythemia vera (PV). Subjects and methods. A total of 61 patients (41 with ET and 20 with PV) were examined. Prior to study enrolment,

Externí odkaz: https://doaj.org/article/5309a997ecb44a6ca0be0a7552cb71f1

Chronic lymphocytic leukemia accompanied by renal failure

Autor: B T Dzhumabaeva, L S Biriukova, É G Gemdzhian, S K Kravchenko, A L Melikian, L S Roshchina

Publikováno v: Терапевтический архив, Vol 86, Iss 12, Pp 37-41 (2014)

AIM. To evaluate the efficiency and safety of monotherapy with bendamustine (B) and therapy with B in combination with rituximab (B + R) in patients with chronic lymphocytic leukemia (CLL) accompanied by renal failure (RF). MATERIALS AND METHODS. The

Externí odkaz: https://doaj.org/article/984d730c03bd4f2ba098b397e8243744

Synchronous and metachronous myeloid and lymphoid tumors

Autor: A L Melikian, T I Kolosheĭnova, S R Goriacheva, I N Subortseva, M V Vakhrusheva, E N Kolosova, A B Sudarikov, A O Abdullaev, V N Dvirnyk, E Iu Varlamova, A M Kovrigina, A G Turkina

Publikováno v: Терапевтический архив, Vol 86, Iss 7, Pp 37-44 (2014)

AIM. To determine the clinical features of multiple primary tumors (MPT) in patients with hemoblastoses, to develop treatment policy for synchronous and metachronous tumors, and to determine the impact of chemotherapy for one disease on the course an

Externí odkaz: https://doaj.org/article/5f12c74511724a4182f454278733a615

A case of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) in a patient with diffuse large B-cell lymphoma and chronic hepatitis B virus infection

Autor: A L Melikian, A M Kovrigina, E A Giliazitdinova, M K Gitis

Publikováno v: Терапевтический архив, Vol 84, Iss 11, Pp 66-70 (2012)

The paper describes a case of diffuse large B-cell lymphoma detected in a patient 13 months after sinus histiocytosis with massive lymphadenopathy (SHML) or Rosai-Dorfman disease (RDD) being diagnosed together with active hepatitis B virus infection.

Externí odkaz: https://doaj.org/article/611a3bea85404b43943ce5a2e7b3906d

Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing

Autor: Gregory K. Robbins, Kristin Razzeca, William J. Towner, Robert W. Shafer, Paolo Troia, Ron M. Kagan, Dennis Israelski, Vici Varghese, George L. Melikian, W. Jeffrey Fessel, Jonathan Taylor, Edwin DeJesus, Soo-Yon Rhee, Jeffrey Burack, Kirsten L. White, Tommy F. Liu, Danielle Porter

Publikováno v: Melikian, GL; Rhee, SY; Varghese, V; Porter, D; White, K; Taylor, J; et al.(2014). Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: Implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing. Journal of Antimicrobial Chemotherapy, 69(1), 12-20. doi: 10.1093/jac/dkt316. UC Berkeley: Retrieved from: http://www.escholarship.org/uc/item/5gg44402
The Journal of antimicrobial chemotherapy, vol 69, iss 1

Objectives: The introduction of two new non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the past 5 years and the identification of novel NNRTI-associated mutations have made it necessary to reassess the extent of phenotypic NNRTI cross-re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cba0ba19f23d521cda10580f36b1d88
https://doi.org/10.1093/jac/dkt316